Sort
10,766 grants matching “checkpoint inhibitor”
Understanding how mitotic kinases drive EMT in breast cancers
$192,638Srikumar P Chellappan · H. Lee Moffitt Cancer Ctr & Res Inst · U54 · FY2018 · CA
Modulating the immuno-metabolic interplay in liver cancer with cryoablation
$192,634Daniel Coman · Yale University · R21 · FY2023 · CA
Evaluation of the tumor microenvironment in serous uterine cancers
$192,489Cornelia M Ulrich · University Of Utah · P30 · FY2024 · CA
Enhanced Immunotherapy by Targeting the Pros1:Macrophage Mer Axis
$192,352Eric S Ubil · University Of Alabama At Birmingham · K22 · FY2020 · CA
Enhanced Immunotherapy by Targeting the Pros1:Macrophage Mer Axis
$192,352Eric S Ubil · University Of Alabama At Birmingham · K22 · FY2021 · CA
Enhanced Immunotherapy by Targeting the Pros1:Macrophage Mer Axis
$192,352Eric S Ubil · University Of Alabama At Birmingham · K22 · FY2022 · CA
Core 2: Glioblastoma Biorepository Core
$192,342Keith L Ligon · Brigham And Women'S Hospital · P01 · FY2018 · CA
ATM (Ataxia Telangiectasia Mutated) signaling through cyclin D1
$192,325Masahiro Hitomi · Cleveland Clinic Lerner Com-Cwru · R21 · FY2011 · NS
Enhancing the efficacy of immunotherapy by optimal use of SMAC mimetics
$192,240Shengqing Gu · University Of Tx Md Anderson Can Ctr · K22 · FY2025 · CA
Enhancing the efficacy of immunotherapy by optimal use of SMAC mimetics
$192,240Shengqing Gu · University Of Tx Md Anderson Can Ctr · K22 · FY2024 · CA
CD73 expression on cancer-associated fibroblasts of Head and Neck Cancers shapes the immune landscape
$192,187Yan Cui · Augusta University · R21 · FY2020 · DE
Full Project 1: Understanding and Targeting of Convergent Immunosuppressive Pathways and Molecular Signaling in HPV-positive and HPV-negative Penile Cancer
$192,039Curtis Pettaway · University Of Tx Md Anderson Can Ctr · U54 · FY2020 · CA
Multi-Ancestry Genetic Analysis of Type 1 Diabetes and Related Conditions
$191,894Aaron Jonathan Deutsch · Massachusetts General Hospital · K23 · FY2025 · DK
A high-throughput screen for inhibitors of Plk1-interacting checkpoint helicase (PICH)
$191,885Duncan J Clarke · University Of Minnesota · R21 · FY2022 · CA
Delivering miR-29a to enhance anti-viral and anti-tumor responses in vivo
$191,875Erietta Stelekati · University Of Miami School Of Medicine · R21 · FY2024 · AI
RADIATION INDUCED G1 CHECKPOINT ARREST IN YEAST
$191,855University Of Chicago · R01 · FY2000 · GM
Developing Therapy for the Treatment of Cholangiocarcinoma
$191,835Karina J Yoon · University Of Alabama At Birmingham · R21 · FY2016 · CA
Counteracting Resistance through Host-Directed Myxovirus Inhibitors
$191,813Richard K. Plemper · Emory University · R21 · FY2011 · AI
Multi-Ancestry Genetic Analysis of Type 1 Diabetes and Related Conditions
$191,750Aaron Jonathan Deutsch · Massachusetts General Hospital · K23 · FY2024 · DK
Airway Immune Response in Critically Ill Children-Precision Medicine in Children At Risk for Acute Respiratory Distress Syndrome
$191,743Jocelyn Rebecca Grunwell · Emory University · K23 · FY2021 · HL
Role of Sirt2 in T Cell Metabolism
$191,611Sungjune Kim · H. Lee Moffitt Cancer Ctr & Res Inst · R37 · FY2023 · CA
Improving decision-making in patients with resectable melanoma and pre-existing autoimmune disease considering immune checkpoint inhibition
$191,520Maria De Los Angeles Lopez-Olivo · University Of Tx Md Anderson Can Ctr · K08 · FY2023 · CA
Germline genetic factors regulating immune response to tumors and their contribution to colorectal cancer risk and prognosis
$191,400Jeroen R Huyghe · Fred Hutchinson Cancer Research Center · R21 · FY2020 · CA
Targeted inhibition of metabolic pathways to enhance radiopharmaceutical therapy
$191,383Sangeeta Ray · Johns Hopkins University · R21 · FY2022 · CA
Noninvasive monitoring and evaluation of anti-tumor responses as a predictive tool
$191,276Mohammad Rashidian · Dana-Farber Cancer Inst · K22 · FY2019 · CA